Device
Percutaneous Ablation
Percutaneous Ablation is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(1)
Other(1)
Detailed Status
Recruiting1
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (100.0%)
Trials by Status
recruiting133%
terminated133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
recruiting
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
NCT06859801
unknown
Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
NCT04892810
terminatedphase_1
Local Ablative Strategies After Endovascular Radioembolization
NCT02611661
Clinical Trials (3)
Showing 3 of 3 trials
NCT06859801
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
NCT04892810
Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
NCT02611661Phase 1
Local Ablative Strategies After Endovascular Radioembolization
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3